Vira-G Eye Gel
Marketer
Pharmatak Opthalmics Pvt Ltd
Salt Composition
Ganciclovir (0.15% w/w)
Overview Vira-G Eye Gel
Cytomega-Guard ophthalmic gel is an antiviral medication indicated for treating cytomegalovirus (CMV) infections in immunocompromised individuals post-organ or bone marrow transplant. This treatment mitigates the risk of vision loss associated with CMV retinitis, a severe ocular infection. Apply Cytomega-Guard gel externally only, as directed by your physician. Always wash hands before and after administration. Hold the applicator near the eye, avoiding contact. Gently dispense the gel into the lower conjunctival sac. Minor, transient eye irritation may occur; however, this typically resolves spontaneously. Report any persistent irritation to your doctor. Refrain from wearing contact lenses during treatment.
Uses of Vira-G Eye Gel
CMV Infection
Major Benefits of Vira-G Eye Gel:
Apply this medication externally only. Administer as directed by your physician, adhering to the prescribed dosage and treatment length. Consult the product label for application instructions prior to use. Position the applicator near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac.
Common Side effects of Vira-G Eye Gel:
- Eye irritation
How to use Vira-G Eye Gel:
Apply this medication externally only. Administer as directed by your physician, adhering to the prescribed dosage and timeframe. Consult the product label for application instructions prior to use. Keep the applicator near the eye, avoiding contact, and gently dispense the medication into the lower conjunctival sac.
How Vira-G Eye Gel works:
Opthalmic antiviral gel, Vira-G, combats viral eye infections by inhibiting viral replication on the cornea. This action halts further virus production, thereby resolving the ocular infection.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Vira-G Eye Gel during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Vira-G Eye Gel while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer into breast milk, posing a risk to the infant.
DrivingUNSAFE
Using Vira-G Eye Gel may lead to adverse reactions that impair driving ability. These reactions can include drowsiness, dizziness, confusion, tremors, loss of equilibrium, or seizures.
KidneyNone
No known drug interactions.
LiverNone
No drug interactions identified.
What if you forget to take Vira-G Eye Gel :
Should you forget a Vira-G Eye Gel application, administer it at your earliest convenience. If, however, your next scheduled application is imminent, omit the missed dose and resume your usual dosing regimen. Never apply a double dose.
Facts to Know About Vira-G Eye Gel
| Label | Value |
|---|---|
| Chemical Category | Base analog nucleotide |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Action Class | Non-HIV antiviral medications |
3,018 People bought this recently